Who Owns Apimeds Pharmaceuticals US Stock?
NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 2.83%
- Held by insiders
- 58.70%
- Institutional holders
- 7
- Institutions 2.8%
- Insiders 58.7%
- Public and other 38.5%
Who owns Apimeds Pharmaceuticals US stock?
Institutional investors own about 2.8% of Apimeds Pharmaceuticals US's shares, spread across 7 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 58.70% of APUS.
The largest institutional holders are Hemenway Trust Company LLC (18.16%), Vanguard Capital Management LLC (4.22%) and Geode Capital Management, LLC (2.33%). Together, the top 7 institutions control 28.3% of shares outstanding. In their latest filings, 3 of the top 7 institutions increased their APUS positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of APUS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Hemenway Trust Company LLC | 274.00K | 18.16% | 0.0% |
| Vanguard Capital Management LLC | 63.65K | 4.22% | -33.6% |
| Geode Capital Management, LLC | 35.11K | 2.33% | -12.3% |
| Vanguard Fiduciary Trust Co | 24.04K | 1.59% | 0.0% |
| Jane Street Group, LLC | 15.99K | 1.06% | +100.0% |
| UBS Group AG | 11.82K | 0.78% | +182.3% |
| Tower Research Capital LLC (TRC) | 1.66K | 0.11% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of APUS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 51.62K | 3.42% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 12.03K | 0.80% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 2.41K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 832 | 0.06% |
Frequently asked questions
Who is the largest shareholder of Apimeds Pharmaceuticals US?
Hemenway Trust Company LLC is the largest institutional shareholder of APUS, owning 18.16% of shares outstanding (274.00K shares) as of its latest 13F filing.
What percentage of Apimeds Pharmaceuticals US is owned by institutions?
Institutions own about 2.8% of APUS shares and 6.8% of the public float.
How much of Apimeds Pharmaceuticals US do insiders own?
Insiders, such as officers and directors, own about 58.70% of APUS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.